ENZO BIOCHEM INC (ENZB)
Data as of , from SEC Form 4 filings.
See up to 3 months of ENZB. The 7-day demo opens the 1M and 3M ranges and puts ENZB on your watchlist.
Start 7-day demoLatest ENZB insider trades
About ENZO BIOCHEM INC (ENZB)
ENZO BIOCHEM INC is an SEC registrant, filing under CIK 0000316253, classified as biological products (no diagnostic substances). We track it alongside the rest of the Health Care sector.
ENZB Form 4 activity by transaction type, last 90 days
No Form 4 activity for ENZB in the last 90 days.
ENZB insider transactions (Form 4)
215 Form 4 filings on record, the earliest from Aug 20, 2025, newest first.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Patricia Eckert - Officer | Derivative | Common Stock | 28,328 | - | - | |
| Patricia Eckert - Officer | Derivative | Stock Option (to acquire shares of Common Stock) | 100,000 | - | - | |
| Patricia Eckert - Officer | Derivative | Stock Option (to acquire shares of Common Stock) | 75,000 | - | - | |
| Patricia Eckert - Officer | Derivative | Stock Option (to acquire shares of Common Stock) | 25,000 | - | - | |
| Patricia Eckert - Officer | Derivative | Stock Option (to acquire shares of Common Stock) | 50,000 | - | - | |
| Patricia Eckert - Officer | Derivative | Stock Option (to acquire shares of Common Stock) | 25,000 | - | - | |
| Kara Cannon - Officer | Derivative | Common Stock | 359,737 | - | - | |
| Kara Cannon - Officer | Derivative | Common Stock | 45,065 | - | - | |
| Kara Cannon - Officer | Derivative | Stock Option (to acquire shares of Common Stock) | 200,000 | - | - | |
| Kara Cannon - Officer | Derivative | Stock Option (to acquire shares of Common Stock) | 200,000 | - | - | |
| Kara Cannon - Officer | Derivative | Stock Option (to acquire shares of Common Stock) | 87,500 | - | - | |
| Kara Cannon - Officer | Derivative | Stock Option (to acquire shares of Common Stock) | 87,500 | - | - | |
| Kara Cannon - Officer | Derivative | Stock Option (to acquire shares of Common Stock) | 55,400 | - | - | |
 Bradley Louis Radoff - Director | Derivative | Common Stock | 4,533,779 | - | - | |
| Bradley Louis Radoff - Director | Derivative | Common Stock | 430,000 | - | - | |
| Jonathan Couchman - Director | Derivative | Common Stock | 142,897 | - | - | |
| Jonathan Couchman - Director | Derivative | Common Stock | 130,000 | - | - | |
| Jonathan Couchman - Director | Derivative | Common Stock | 40,000 | - | - | |
| Jonathan Couchman - Director | Derivative | Common Stock | 15,000 | - | - | |
| Jonathan Couchman - Director | Derivative | Common Stock | 277,237 | - | - | |
| Steven J. Pully - Director | Derivative | Common Stock | 239,992 | - | - |
ENZB insider trading FAQ
What is the latest insider trade for ENZB?
ENZO BIOCHEM INC (ENZB) has filed no insider reports in the last 90 days. The most recent on record is dated 2025-08-20. The full record for ENZB runs to 5 Form 4 filings, the earliest from 2025-08-20. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying ENZB stock?
No insider purchases of ENZB were filed in the last 90 days.
How many insiders are selling ENZB stock?
No insider sales of ENZB were filed in the last 90 days.
Where can I see ENZB SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects ENZB Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
5The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Patricia Eckert view on EDGAR
- - Kara Cannon view on EDGAR
- - Bradley Louis Radoff view on EDGAR
- - Jonathan Couchman view on EDGAR
- - Steven J. Pully view on EDGAR
Related companies with recent insider activity
Learn more
- What the Form 4 transaction codes mean
- Grants, option exercises, gifts and tax withholding are not trades on the market. The codes say which is which.
- Insider activity in Health Care
- Where ENZB's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow ENZB with a 7-day demo
- ENZB on your watchlist
- Every ENZB Form 4 filing on record
- Up to 3 months of ENZB price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
